Why the study?
Due to concerns over CSFV reemergence and the negative aspects of mass stamping out policies, vaccination is key, warranting active investigation into more effective vaccines.
This review highlights the need for continued investigation into more effective vaccines against Classical Swine Fever Virus to control future outbreaks in endemic regions.
May inform CSF vaccine strategies amid reemergence; leaves open optimal control approaches in endemic areas.
Classical swine fever (CSF) is, without any doubt, one of the most devasting viral infectious diseases affecting the members of Suidae family, which causes a severe impact on the global economy. The reemergence of CSF virus (CSFV) in several countries in America, Asia, and sporadic outbreaks in Europe, sheds light about the serious concern that a potential global reemergence of this disease represents. The negative aspects related with the application of mass stamping out policies, including elevated costs and ethical issues, point out vaccination as the main control measure against future outbreaks. Hence, it is imperative for the scientific community to continue with the active investigations for more effective vaccines against CSFV. The current review pursues to gather all the available information about the vaccines in use or under developing stages against CSFV. From the perspective concerning the evolutionary viral process, this review also discusses the current problematic in CSF-endemic countries.
No takes yet. Share an insight, caveat, or question.
Coronado et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: